KATHERINE NOBLE: Open Payments
NPI 1356394787 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 10 payments from 5 companies in 2025. Trend: 2023 $2,390 · 2024 $2,144 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, XIFAXAN, UBRELVY, Ozempic, OTEZLA.
Industry payments across KY — which companies pay providers there.
